Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
Eli Lilly(LLY) stock is priced at $1,183.70, giving the company a market capitalization of 1.11T. It carries a P/E multiple of 40.26 and pays a dividend yield of 0.56%.
On 2026-09-29, Eli Lilly(LLY) stock traded between a low of $1,168.47 and a high of $1,192.94. Shares are currently priced at $1,183.70, which is +1.3% above the low and -0.8% below the high.
The Eli Lilly(LLY)'s current trading volume is 855.69K, compared to an average daily volume of 2.32M.
During the past year, Eli Lilly(LLY) stock moved between $716.08 at its lowest and $1,292.65 at its peak.
During the past year, Eli Lilly(LLY) stock moved between $716.08 at its lowest and $1,292.65 at its peak.
LLY News
Novo Nordisk A/S (NYSE:NVO) announced on Tuesday new real-world evidence demonstrating that escalating semaglutide dosage reduces major adverse cardiovascular e...
Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. This Phase 2 study, officially titled “A Phase 2, Parallel-Group, Double-Blind...
Eli Lilly and Co. (NYSE:LLY) revealed new analysis data indicating that its medications, Zepbound and Foundayo, yielded superior weight loss and blood sugar con...
Analyst ratings
84%
of 32 ratingsMore LLY News
Eli Lilly and Company (NYSE: LLY) launched the Lilly Change the Course Commitment on Monday, a global health initiative aiming to treat as many people with diab...
Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of cou...
Eli Lilly (LLY) announced results from a new analysis showing that Zepbound – tirzepatide – 10 mg and 15 mg, a dual GIP and GLP-1 receptor agonist, delivered gr...
(RTTNews) - Tuesday, Eli Lilly (LLY) said Foundayo 17.2 mg showed greater weight loss and A1C reductions than oral semaglutide 25 mg in an indirect treatment co...
Eli Lilly (LLY) CEO Dave Ricks said in an interview with Bloomberg that he sees the company doing more deals in untapped areas and sees deals that are “a little...
The U.S. Food and Drug Administration granted expanded approval to Eli Lilly and Co.’s (NYSE:LLY) Olumiant (baricitinib), allowing adolescents aged 12 and older...
Investing in a top company can offer safety and stability, but oftentimes, the potential upside can also be limited. Take Eli Lilly (LLY +0.13%) as a prime exam...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.